S&P Places Johnson & Johnson on CreditWatch Negative
S&P Global Ratings placed Johnson & Johnson on CreditWatch with negative implications, citing its nearly $15 billion deal to acquire mental-illness drug developer Intra-Cellular Therapies.
MarketWatch12m
As wildfires and other disasters make owning a home riskier, how much of your net worth should be tied up in your house?
The wildfires that have ravaged the Los Angeles area for a week have left the homes of ultra w ealthy and middle-class ...
MarketWatch16m
EP Corporate Group: Acquisition of International Distribution Services Received Merger Control Clearance From European Commission
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
MarketWatch16m
WELL Health Technologies Shares Rise After Updating M&A Plans
WELL Health Technologies shares rose after the company said its momentum when it comes to acquisitions to continue in 2025. The stock was up 2% to 6.75 Canadian dollars ($4.69). Shares touched a ...
Stock Market Today: Dow edges lower, S&P 500 and Nasdaq give back earlier gains as investors await CPI report
Follow here to see if Wall Street stocks can rebound after a tough start to the year amid surging Treasury yields ...
MarketWatch47m
Charles River Laboratories Stock Falls 6% on Dim FY25 Outlook
Shares for Charles River Laboratories slipped after the company said it expects revenue to decline in 2025. Shares of the Massachusetts-based pharmaceutical company were recently down 6% to $178.50 in ...
PPL to Eliminate Chief Operating Officer Post as Sullivan Retires
PPL Corp.'s chief operating officer is retiring, and the energy company is eliminating the post. PPL on Tuesday said Francis Sullivan, who joined the Allentown, Pa., company in October 2021 and has ...
Silvaco Shares Rise After Preliminary Results Show Swing to Profit
In morning trading, the shares were 7% higher at $8.04. The stock is down about 27% over the past three months. Silvaco said it expects revenue of between $17.7 million and $18.1 ...
Risk appetite among U.S. stock-market investors has deteriorated in January: S&P Global
Wall Street has been reassessing its risk tolerance in the first month of 2025 as investors' optimism about the macroeconomic ...
This is what investors want to see from fourth-quarter corporate earnings
The first few earnings reports from S&P 500 firms have already started to trickle in. But the fourth-quarter earnings ...
US To Sell $90 Bln In Reopened 8-Week Bills Thu
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
Firefly Neuroscience Shares Double After Move to Advance BNA Platform
Firefly Neuroscience shares doubled to $3.90 Tuesday after the company said it is advancing its research used to assess a patient's brain age--an estimation of the biological age of a person's ...